SCHEMBL10077084

SCHEMBL10077084

CCOC(=O)CCCN(CCOC1=CC(CO)NC(CO)=C1)S(=O)(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
MAPK1 P28482 1/20 0.39
MAPT P10636 4/20 0.36
MEN1 O00255 3/20 0.34
USP2 O75604 1/20 0.34
RAB9A P51151 1/20 0.33
PKM P14618 2/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 1/20 0.32
HRH2 P25021 1/20 0.32
HRH1 P35367 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
PTPN1 P18031 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10076958 0.89 TDP1 (0.36) ALDH1A1KMT2ATDP1MAPK1MAPT
SCHEMBL526306 0.78 ALDH1A1 (0.42) ALDH1A1KMT2ATDP1MAPK1MAPT
SCHEMBL10077797 0.74 HIF1A (0.35) ALDH1A1KMT2ATDP1MAPK1MAPT
SCHEMBL526307 0.74 ALDH1A1 (0.41) ALDH1A1KMT2ATDP1MAPK1MAPT
SCHEMBL22117258 0.66 RAB9A (0.44) ALDH1A1KMT2ATDP1MAPK1MAPT
SCHEMBL968214 0.66 VCAM1 (0.54) ALDH1A1KMT2AMAPK1MAPTMEN1
SCHEMBL2337212 0.66 CA1 (0.51) ALDH1A1KMT2ATDP1MAPK1MAPT
SCHEMBL4381121 0.65 KMT2A (0.50) KMT2ATDP1MEN1PKMCA12
SCHEMBL20564486 0.65 KMT2A (0.58) ALDH1A1KMT2ATDP1MAPK1MAPT
SCHEMBL31039461 0.65 KMT2A (0.58) ALDH1A1KMT2ATDP1MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012014147-A1 ANTICANCER DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-02-02 WO disclosed